Edges in Network
| Network | GSE14208_egf1520 - GSE14208 - SiGN-BN HC+Bootstrap |
| Network Description | Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy |
| Node | SPRY2 |
| Upstream (Parents) |
|---|
| (<<) ANXA2 → SPRY2 |
| (<<) BMPR1A → SPRY2 |
| (<<) CASP4 → SPRY2 |
| (<<) CD4 → SPRY2 |
| (<<) CDK8 → SPRY2 |
| (<<) CTNNB1 → SPRY2 |
| (<<) CXADR → SPRY2 |
| (<<) CXCL14 → SPRY2 |
| (<<) DLX2 → SPRY2 |
| (<<) DUSP5 → SPRY2 |
| (<<) FGFR2 → SPRY2 |
| (<<) FUT2 → SPRY2 |
| (<<) HMGA2 → SPRY2 |
| (<<) JUN → SPRY2 |
| (<<) MAPK13 → SPRY2 |
| (<<) MREG → SPRY2 |
| (<<) NCOR1 → SPRY2 |
| (<<) NFKB1 → SPRY2 |
| (<<) NFKBIE → SPRY2 |
| (<<) ODC1 → SPRY2 |
| (<<) PLA2G4A → SPRY2 |
| (<<) RNASE4 → SPRY2 |
| (<<) SERPINB5 → SPRY2 |
| (<<) SPINK1 → SPRY2 |
| (<<) TIMP2 → SPRY2 |
| (<<) TNFRSF1A → SPRY2 |
| Downstream (Children) |
|---|
| SPRY2 → CDR2 (>>) |
| SPRY2 → DUSP9 (>>) |
| SPRY2 → E2F3 (>>) |
| SPRY2 → FZD10 (>>) |
| SPRY2 → IVL (>>) |
| SPRY2 → KLF6 (>>) |
| SPRY2 → KYNU (>>) |
| SPRY2 → MAP3K14 (>>) |
| SPRY2 → NMU (>>) |
| SPRY2 → PABPC3 (>>) |
| SPRY2 → PHLDA2 (>>) |
| SPRY2 → PPP3CA (>>) |
| SPRY2 → RARA (>>) |
| SPRY2 → ROBO3 (>>) |
| SPRY2 → ROCK2 (>>) |
| SPRY2 → SLPI (>>) |
| SPRY2 → TP53 (>>) |
| SPRY2 → TSC22D1 (>>) |
| SPRY2 → UAP1 (>>) |
| SPRY2 → UGDH (>>) |
| SPRY2 → VAV1 (>>) |
| SPRY2 → VAV3 (>>) |
| SPRY2 → ZNF750 (>>) |
